Since the outbreak at the end of 2019, COVID-19 has become a significant challenge in global public health history. This infectious disease caused by the novel coronavirus (SARS-CoV-2) quickly evolved into an urgent public health event of international concern. The virus spreads through respiratory droplets and contact, with initial symptoms resembling those of a common cold, but severe cases can lead to multiple organ failure. The global scientific community continues to research its transmission mechanisms and treatment options, with vaccine development viewed as key to controlling the pandemic.
The characteristics of COVID-19 give it a high transmissibility and the ability for asymptomatic transmission during the incubation period. Infected individuals may spread the virus without showing symptoms. Statistics from the World Health Organization (WHO) indicate that older adults and patients with chronic diseases are at higher risk of severe illness after infection. With the emergence of viral variants, prevention strategies have also been adjusted, including the emphasis on booster vaccinations, mask-wearing, and maintaining social distance.
The SARS-CoV-2 virus belongs to the coronavirus family, and after its spike protein binds to the human ACE2 receptor, it can enter human cells for replication. This virus likely originated from an animal host and rapidly spread through human-to-human transmission. The RNA genome of the virus is prone to mutations, leading to the emergence of different variants such as Alpha, Delta, and Omicron, with Omicron exhibiting several times the transmissibility of the original strain.
Risk factors for infection can be categorized into physiological and environmental factors. From a physiological perspective, individuals over 65 years old, those with cardiovascular or pulmonary diseases, and those with weakened immune systems are considered high-risk groups. Environmental risks include healthcare workers, workers in crowded places (such as transportation personnel), and living environments where social distancing cannot be maintained. Genetic studies also indicate that certain populations may be more sensitive to the virus due to hereditary factors.
Symptoms after infection can vary greatly, and after an incubation period of about 10-14 days, patients may exhibit the following typical symptoms:
Severe cases can develop into acute respiratory distress syndrome (ARDS), leading to respiratory failure. A small number of patients may experience "long COVID" symptoms after recovery, including persistent fatigue and cognitive dysfunction as long-term sequelae. In children, infections are usually mild, but rare complications such as MIS-C (multisystem inflammatory syndrome in children) require close monitoring.
The diagnostic process typically includes three stages: clinical assessment, laboratory testing, and imaging studies. Rapid antigen tests can provide preliminary results within 15 minutes, but PCR nucleic acid testing remains the gold standard for diagnosis due to its high sensitivity. Physicians will decide whether to perform chest X-rays or CT scans based on the severity of symptoms and risk factors to assess lung infiltration.
In epidemiological investigations, contact tracing and cluster infection analysis are also important diagnostic aids. Special populations, such as pregnant women or immunosuppressed patients, may require more cautious diagnostic processes. Recent studies have also shown that blood markers such as C-reactive protein (CRP) and D-dimer can help assess disease severity and the risk of thromboembolic complications.
Patients with mild symptoms are primarily treated symptomatically, including antipyretics and adequate hydration. Antiviral medications such as Paxlovid and Molnupiravir should be used within five days of symptom onset to block viral replication. Severe patients may require hospitalization for treatments including high-flow oxygen therapy, ventilator support, and anticoagulants to prevent thrombosis.
In terms of immunotherapy, monoclonal antibody therapies remain effective against specific variants, but close monitoring for the development of drug resistance is necessary. Traditional Chinese medicine is used in some regions for symptom relief, but its efficacy requires further clinical trials for validation. Rehabilitation therapy is crucial for patients in recovery, as it can improve lung function and physical condition.
Vaccination is currently the most effective preventive strategy, with three doses significantly reducing the risk of severe illness and death. The immune response after vaccination varies by age and underlying conditions, and individuals over 60 should receive booster shots to maintain protection. Proper mask usage can block over 80% of droplet transmission, with N95 masks filtering small droplets more effectively than standard surgical masks.
Environmental preventive measures include regularly cleaning frequently touched surfaces, ensuring indoor ventilation, and avoiding crowded places. Individuals with weakened immune systems may require additional pre-exposure prophylactic medications. Global research indicates that maintaining a healthy diet, regular exercise, and adequate sleep can enhance the immune system's antibody response to the virus.
Immediate medical attention should be sought if the following warning symptoms occur:
Mild patients whose symptoms persist for more than ten days without improvement, or who experience a fever again after having one, should return for re-evaluation. High-risk groups, such as pregnant women and organ transplant recipients, are advised to seek professional medical evaluation early, even with mild symptoms.
The primary function of vaccines is to reduce the risk of severe illness and death, not to completely block infection. Even if breakthrough infections occur, vaccinated individuals typically experience milder symptoms and shorter illness duration. The World Health Organization recommends continuing booster vaccinations to maintain protection, along with hand hygiene and ventilation measures.
How should home care be managed when experiencing fever and difficulty breathing?Fever can be managed with antipyretics and adequate hydration, and ventilation should be ensured while resting in a sitting position during difficulty breathing. If blood oxygen levels drop below 94% or symptoms continue to worsen, immediate medical attention is required. Chronic disease patients should continue their prescribed medications and maintain contact with healthcare providers.
Does wearing multiple layers of masks provide more effective virus transmission prevention?Incorrectly stacking multiple cloth masks may reduce breathability, thereby increasing the risk of infection. It is recommended to wear a properly fitted medical surgical mask or N95 mask and avoid touching the mask's surface. In high-risk settings, a face shield can be added, but primary protection still relies on the mask's fit.
How long after recovering from infection can one resume vigorous exercise or high-intensity work?Mild patients typically need to rest for at least 7 to 10 days and gradually resume activities after symptoms have completely resolved. Those who have experienced pneumonia or cardiopulmonary symptoms should have their heart and lung function evaluated by a doctor before resuming exercise. Engaging in vigorous activities too soon may trigger complications like myocarditis, requiring special attention.
Is the statement "COVID-19 only spreads through droplets" accurate?This statement is incomplete. The virus can spread through droplets, contact with contaminated surfaces, and aerosols in enclosed spaces. Additional protection is required in closed environments with prolonged exposure to high concentrations of the virus (such as hospital wards). Maintaining ventilation and wearing masks remain key protective measures in daily life.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
